Sai Life Sciences Ltd

Science earns trust when it follows the evidence. Our Director, Analytical R&D, Anji Reddy Bandi, discusses why transparency, objectivity, and scientific integrity are at the heart of every client partnership. #Sailifesciences #analytical #chemistry #cdmo #cro #pharma #drugdevelopment

In our recent webinar on ‘Integrated Drug Discovery: Accelerating the Journey from Target to Clinic,’ our panel explored what integration really means in practice. Is it simply about bringing Chemistry, Biology, DMPK and Project Management together? Or is it about creating a team that thinks beyond individual functions, connects the science and solves complex problems together? Watch our expert panel share what it takes to make an IDD approach truly integrated. #sailifesciences #drugdiscovery #drugdevelopment #integratedservices #crdmo #cro #cdmo #pharma #science Mabi jaleel, Santosh Kulkarni, Vamsi Madgula, Lakshmi Iyer, PMP®, LSSBB, Victoria Steadman

It started with a question: What does freedom mean to you? By the end of the day, the canvas had a lot to say. To speak your mind without fear. To make your own choices. To be yourself. To challenge injustice. To give others the freedom to be who they are. Every answer was personal. And together, they offered a lovely reminder of how much freedom can mean in everyday life. Around it, the day unfolded with the Tricolour, patriotic songs, games, laughter and plenty of time together. A celebration of our freedom—and a moment to reflect on what we do with it. Happy Independence Day. #Sailifesciences #IndependenceDay #Freedom #LifeAtSai #pharma #crdmo

Every dataset tells part of the story. Our Head of In Vivo Pharmacology, Sumit Chaudhary, explains how connecting scientific evidence helps transform complex biology into confident decision-making. #sailifesciences #InVivoPharmacology #pharma #cro #drugdiscovery

CPHI Milan is just around the corner, and we’re looking forward to three days of good conversations, new ideas and time with the people we work with—and the people we’re yet to meet. For us, this year comes at an exciting time. We’ve been investing in our science, expanding our capabilities and building new ways to support our customers as their programs evolve. There’s plenty we’re looking forward to sharing in Milan. And plenty we’re looking forward to hearing about, too. We’re Ready for More. See you at CPHI Milan. #SaiLifeSciences #ReadyForMore #CPHIMilan #CPHI2026 #pharma #drugdevelopment #drugdiscovery

As a child, Matt Ling was fascinated by understanding how things worked. Chemistry appealed to him because, as he puts it, building molecules felt "a bit like Lego"—piecing together something meaningful, one block at a time. That curiosity eventually led him to a career in pharmaceuticals, driven by the opportunity to develop medicines that make a difference. Today, as Senior Director – Drug Product at Sai Life Sciences, Matt brings more than three decades of industry experience to one of the company's newest growth areas. What excites him most is the opportunity to build something from the ground up and help shape new capabilities. Outside work, he enjoys running, cycling, and exploring new places on foot. An avid reader with eclectic tastes, he's equally happy training for his next marathon or unwinding with a good book. We're delighted to welcome Matt to Sai Life Sciences and look forward to the experience, curiosity, and leadership he brings to our growing Drug Product team. #sailifesciences #newjoiner #formulations #drugdiscovery #drugdevelopment

The pressure to accelerate drug development has never been greater. But speed alone isn't enough—every decision made during scale-up must be backed by deeper process understanding and robust data. In a recent interview with Brian K. Buntz, Editor-in-Chief of Drug Discovery & Development, Tuneer Ghosh, President – CMC, shares how Sai Life Sciences is taking an information-dense approach to scale-up—combining process science, digital technologies and cross-functional collaboration to help pharma innovators compress timelines while reducing development risk. Read the full article here: https://lnkd.in/gV6evb7M #Sailifesciences #cmc #drugdevelopment #scaleup #speed #pharma #cdmo #crdmo #drugdiscovery

Innovation begins when we challenge what's possible. Our Director, Operations and Continuous manufacturing, Lalit Patil, shares how science-led thinking and engineering ingenuity help overcome complex process development challenges. #sailifesciences #flowchemistry #chemistry #pharma #cdmo #cro #drugdevelopment #innovation #manufacturing

Drug discovery is as much about asking the right questions as it is about finding the right molecule. Thank you, Dr. Bharat Lagu, for an insightful masterclass on "Identifying 'Best in Class' H3 Inverse Agonists for the Treatment of Narcolepsy." Drawing on more than three decades of drug discovery experience, Dr. Lagu shared how receptor occupancy—rather than brain pharmacokinetics— served as a powerful guide for lead optimization. He also walked participants through the scientific rationale, differentiation strategy, and optimization journey that led to the identification of the clinical candidate LML-134, offering valuable perspectives on translating medicinal chemistry into meaningful therapeutic innovation. The session sparked engaging discussions and provided our scientists with practical insights into modern lead optimization strategies for CNS drug discovery. #SaiLifeSciences #MedicinalChemistry #DrugDiscovery #Narcolepsy #LeadOptimization #ScientificExcellence #LearningAndDevelopment

Scientific excellence grows stronger when we learn together. Recently, our CMC R&D leaders came together in Hyderabad for a day of discussion, reflection, and alignment around the principles that shape how we work—Ownership, Collaboration, and Continuous Learning. Our conversations centered on advancing scientific excellence across the work we do with a strong emphasis on deepening process understanding. We covered topics around reaction mechanism, impurity control, reaction quench, work-up and scale-up to plant - integrating thoughts from colleagues across chemistry, analytical science and engineering disciplines. We also explored how data rich experimentation and science-led risk assessment help translate laboratory insights into robust manufacturing processes and how open access analytical methodologies can accelerate and enhance our scientific decision-making. These conversations are an important part of our ongoing journey to build on our scientific strengths, continuously enhance the way we work, and deliver greater value for our customers. Scientific excellence is not a destination but a continuous pursuit, driven by collaboration, curiosity, and a shared commitment to learning. #Sailifesciences #cmc #scientificexcellence #learning #analytical #processdevelopment